Gene region | Polymerase chain reaction fragment | Nucleotide change | Amino acid change | Number of total heterozygousa cases | Male breast cancer families | Prostate cancer families | BCoR-L1 haplotype sharing families | Number of heterozygous controls | Previously reportedb | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exon 4 | 4a | c.516T>C | p.N172N | 2/48 | 4.2% | - | - | 2/9 | 22.2% | 0/101 | 0% | No | ||
Exon 4 | 4b | c.625G>A | p.G209S | 6/48 | 12.5% | 2/29c | 6.9% | 3/15 | 20.0% | 2/9 | 22.2% | 18/73 | 24.6% | Yes |
Intron 5 | 6 | c.3608-156C>T | - | 2/48 | 4.2% | - | - | 2/9 | 22.2% | 0/99 | 0% | No | ||
Intron 13 | 13 | c.5075+21C>T | - | 10/48 | 20.8% | 5/29c | 17.2% | 3/15 | 20.0% | 2/9 | 22.2% | 26/102 | 25.5% | Yes |